4.8 Editorial Material

National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B

期刊

HEPATOLOGY
卷 49, 期 5, 页码 S4-S12

出版社

JOHN WILEY & SONS INC
DOI: 10.1002/hep.22946

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Fatigue and endocrine symptoms among women with early breast cancer randomized to endocrine versus chemoendocrine therapy: Results from the TAILORx patient-reported outcomes substudy

Sofia F. Garcia, Robert J. Gray, Joseph A. Sparano, Amye J. Tevaarwerk, Ruth C. Carlos, Betina Yanez, Ilana F. Gareen, Timothy J. Whelan, George W. Sledge, David Cella, Lynne I. Wagner

Summary: The study found that patients with early-stage breast cancer who received adjuvant chemoendocrine therapy reported greater fatigue and endocrine symptoms at early time points, but these differences lessened over time, demonstrating early chemotherapy effects more than long-term ones. Treatment arm differences in endocrine symptoms were more evident in postmenopausal patients.

CANCER (2022)

Review Gastroenterology & Hepatology

An Approach to the Primary and Secondary Prevention of Gastric Cancer in the United States

Robert J. Huang, Meira Epplein, Chisato Hamashima, Il Ju Choi, Eunjung Lee, Dennis Deapen, Yanghee Woo, Thuy Tran, Shailja C. Shah, John M. Inadomi, David A. Greenwald, Joo Ha Hwang

Summary: This study shows that the burden of GC is unequally distributed in the US, predominantly affecting Asian, African American, Hispanic, and American Indian/Alaskan Native populations. International studies have provided substantial evidence supporting the effectiveness of strategies such as H. pylori testing and treatment, as well as endoscopic screening in reducing GC-specific mortality. However, there is a lack of data from US sources. Therefore, there is an urgent need for cancer prevention trials targeting high-risk immigrant and minority populations in the US, and for the development of national strategies for GC prevention.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

How to Succeed in Digestive Research

Amnon Sonnenberg, John M. Inadomi

GASTROENTEROLOGY (2022)

Editorial Material Gastroenterology & Hepatology

Post-endoscopy Esophageal Neoplasia in Barrett's Esophagus: Consensus Statements From an International Expert Panel

Sachin Wani, Rena Yadlapati, Siddharth Singh, Tarek Sawas, David A. Katzka, Matthew Hall, Jacques Bergman, Marcia I. Canto, Amitabh Chak, Douglas A. Corley, Gary W. Falk, Rebecca C. Fitzgerald, Rehan Haidry, John M. Inadomi, Prasad G. Iyer, Jennifer Kolb, Srinadh Komanduri, Vani Konda, Elizabeth A. Montgomery, V. Raman Muthusamy, Joel H. Rubenstein, Felice Schnoll-Sussman, Nicholas J. Shaheen, Michael Smith, Stuart Spechler, Ravy Vajravelu

GASTROENTEROLOGY (2022)

Editorial Material Oncology

Linking Structural Racism and Discrimination and Breast Cancer Outcomes: A Social Genomics Approach

Ruth C. Carlos, Samilia Obeng-Gyasi, Steven W. Cole, Bradley J. Zebrack, Etta D. Pisano, Melissa A. Troester, Lava Timsina, Lynne I. Wagner, Jon A. Steingrimsson, Ilana Gareen, Christoph I. Lee, Alyce S. Adams, Consuelo H. Wilkins

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Assessment of Racial Disparity in Survival Outcomes for Early Hormone Receptor-Positive Breast Cancer After Adjusting for Insurance Status and Neighborhood Deprivation A Post Hoc Analysis of a Randomized Clinical Trial

Gelareh Sadigh, Robert J. Gray, Joseph A. Sparano, Betina Yanez, Sofia F. Garcia, Lava R. Timsina, Samilia Obeng-Gyasi, Ilana Gareen, George W. Sledge, Timothy J. Whelan, David Cella, Lynne Wagner, Ruth C. Carlos

Summary: This study evaluated the impact of racial disparities on clinical outcomes in breast cancer patients, showing that Black women had significantly shorter relapse-free interval and overall survival compared to White women. Factors such as insurance coverage and neighborhood deprivation index do not fully explain this disparity.

JAMA ONCOLOGY (2022)

Article Oncology

Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients

Samilia Obeng-Gyasi, Noah Graham, Shaji Kumar, Ju-Whei Lee, Susanna Jacobus, Matthias Weiss, David Cella, Fengmin Zhao, Edward H. Ip, Nathaniel O'Connell, Fangxin Hong, Devin J. Peipert, IIana. F. Gareen, Lava R. Timsina, Robert Gray, Lynne I. Wagner, Ruth C. Carlos

Summary: The objective of this study is to examine the association between neighborhood socioeconomic status (nSES) and baseline allostatic load (AL) and clinical trial endpoints in patients enrolled in the E1A11 therapeutic trial in multiple myeloma (MM). The study found that an increase in baseline AL was associated with higher odds of high fatigue at baseline and worse overall survival. Additionally, high nSES was associated with worse baseline bother. However, there was no association between AL or nSES and symptom burden, non-completion of induction therapy, or progression-free survival.

BLOOD CANCER JOURNAL (2022)

Article Infectious Diseases

Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network

Sara Y. Tartof, Fagen Xie, Ruchi J. Yadav, Karen J. T. Wernli, Emily T. A. Martin, Edward A. Belongia, Manjusha K. Gaglani, Richard K. Zimmerman, H. Keipp Talbot, Natalie Thornburg, Brendan Flannery, US Flu VE Network Investigators

Summary: This study assessed the combined protection conferred by prior SARS-CoV-2 infection and COVID-19 vaccination against COVID-19-associated acute respiratory illness. The results showed that among previously uninfected patients, three doses of mRNA COVID-19 vaccine had an effectiveness of 97% against the Delta variant, but the effectiveness against the Omicron variant was not statistically significant. Among previously infected patients, the three-dose vaccine had a protection rate of 57% against the Omicron variant, and the effectiveness against the Delta variant could not be estimated.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2023)

Article Infectious Diseases

Effectiveness of first and second COVID-19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021-July 2022

Joshua G. Petrie, Jennifer P. King, David L. McClure, Melissa A. Rolfes, Jennifer K. Meece, David Pattinson, Gabriele Neumann, Yoshihiro Kawaoka, Edward A. Belongia, Huong Q. McLean

Summary: During the circulation of the Omicron variant virus, a monovalent COVID-19 mRNA booster vaccine showed significant protection against SARS-CoV-2 infection, but the effectiveness decreased over time. A second booster did not provide significant protection for adults aged 50 and above. Encouraging the uptake of recommended bivalent boosters is advised to enhance protection against the Omicron BA.4/BA.5 sublineages.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2023)

Article Medicine, General & Internal

Significant Incidental Findings in the National Lung Screening Trial

Ilana F. Gareen, Roee Gutman, JoRean Sicks, Tina D. Tailor, Richard M. Hoffman, Amal N. Trivedi, Efren Flores, Ellen Underwood, Jerson Cochancela, Caroline Chiles

Summary: This retrospective study analyzed the significant incidental findings (SIFs) in patients undergoing low-dose computed tomography (LDCT) lung screening. The study found a high prevalence of SIFs, most of which were considered reportable and required follow-up. Standardization of SIF reporting in future screening trials is recommended.

JAMA INTERNAL MEDICINE (2023)

Article Immunology

Influenza vaccination coverage among persons ages six months and older in the Vaccine Safety Datalink in the 2017-18 through 2022-23 influenza seasons

Stephanie A. Irving, Holly C. Groom, Edward A. Belongia, Bradley Crane, Matthew F. Daley, Kristin Goddard, Lisa A. Jackson, Tia L. Kauffman, Tat'Yana A. Kenigsberg, Leslie Kuckler, Allison L. Naleway, Suchita A. Patel, Hung Fu Tseng, Josh T. B. Williams, Eric S. Weintraub

Summary: In the United States, influenza vaccination coverage increased from 2017-18 to 2019-20, then decreased to the lowest level in the 2022-23 season. The lowest coverage was observed among males, individuals aged 18-49, non-Hispanic Black people, and those without high-risk conditions.

VACCINE (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Utilization of Diagnostic Procedures After Lung Cancer Screening in the National Lung Screening Trial

Meng-Yun Lin, Tao Liu, Constantine Gatsonis, JoRean D. Sicks, Stephannie Shih, Ruth C. Carlos, Ilana F. Gareen

Summary: This study examined the utilization patterns of diagnostic procedures after lung cancer screening among participants enrolled in the National Lung Screening Trial. The study found that the utilization of imaging and invasive procedures varied depending on the screening modality, with a lower utilization rate for low-dose CT compared to chest X-ray. The utilization of invasive and surgical procedures was also lower after subsequent screening examinations compared to baseline screening.

JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY (2023)

Meeting Abstract Cardiac & Cardiovascular Systems

HYPERTENSION, CARDIOVASCULAR EVENTS AND SURVIVAL IN RENAL CELL CARCINOMA AND THYROID CANCER PATIENTS TREATED WITH VEGFR TYROSINE KINASE INHIBITORS

Vivek Narayan, Tao Liu, Yunjie Song, Joshua Mitchell, Jorean Sicks, Ilana F. Gareen, Lova Sun, Srinivas Denduluri, Ciaran P. Fisher, Jesse Manikowski, Mark Wojtowicz, Joseph Vadakara, Naomi Balzer Haas, Kenneth B. Margulies, Bonnie Ky

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Meeting Abstract Gastroenterology & Hepatology

ENDOSCOPIC SURVEILLANCE OF INTESTINAL METAPLASIA OF THE ESOPHAGOGASTRIC JUNCTION: A COST-EFFECTIVENESS ANALYSIS

Ji Yoon Yoon, Julian A. Abrams, Joel H. Rubenstein, Shailja Shah, Jake Kim, John M. Inadomi, David A. Katzka, Michelle K. Kim, Chin Hur

GASTROENTEROLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

ENDOSCOPIC SCREENING FOR ESOPHAGEAL ADENOCARCINOMA IN VARIED POPULATIONS: A COMPARATIVE COST-EFFECTIVENESS ANALYSIS

Joel H. Rubenstein, Amir-Houshang Omidvari, Brianna Lauren, William D. Hazelton, Francesca Lim, Sarah Xinhui Tan, Chung Yin Kong, Minyi Lee, Ayman Ali, Chin Hur, John M. Inadomi, Georg Luebeck, Iris Lansdorp-Vogelaar

GASTROENTEROLOGY (2022)

暂无数据